by The global biopharmaceutical CMO and CRO market size was valued at USD 30.1 billion in 2020, and is predicted to be worth around USD 60.1 billion by 2030, registering a CAGR of 7.6% during the forecast period 2022 to 2030.
Biopharmaceutical CMO and CRO Market (By Source: Mammalian, Non-mammalian; By Service Type: Contract Manufacturing, Contract Research; By Product: Biologics, Biosimilars) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39095
Report Coverage
| Report Scope | Details |
| Market Size | US$ 60.1 billion by 2030 |
| Growth Rate | CAGR of 7.6% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Source, Service, Product |
Growth Factors
There was unprecedented growth in 2020 due to the COVID-19 pandemic. The rising investments in the biopharmaceutical industry by the prominent participants to enhance their productivity and efficiency have driven the bio manufacturers to increase their focus on outsourcing activities. Currently, biopharma companies have begun outsourcing the resource and capital-intensive steps and, in a few cases, the entire chain of biomanufacturing, thereby boosting the demand for contract-based services.
The robustness of venture capital investments is one of the important supportive factors that has created opportunities for the growth of CMOs. Venture capital funds are considered more reliable than public equity. An increase in the availability of venture funds for life sciences is expected to bolster the growth of CMOs. However, these CMOs & CROs are expected to face competition from in-house departments of pharmaceutical & biotechnology companies. Several big pharma companies like Novartis announced to maintain and expand their biomanufacturing processes in-house over the coming years.
Key Players
- Boehringer Ingelheim GmbH
- Lonza Group AG
- Inno Biologics Sdn Bhd
- Rentschler Biopharma SE
- JRS Pharma
- Biomeva GmbH
- ProBioGen AG
- Fujifilm Diosynth Biotechnologies U.S.A., Inc.
- Toyobo Co., Ltd.
- Samsung Biologics
Market Segmentation
- By Source
- Mammalian
- Non-mammalian
- By Service Type
- Contract Manufacturing
- Process Development
- Downstream
- Upstream
- Fill & Finish Operations
- Analytical & QC Studies
- Packaging
- Process Development
- Contract Research
- Oncology
- Inflammation & Immunology
- Cardiology
- Neuroscience
- Others
- Contract Manufacturing
- By Product
- Biologics
- Monoclonal antibodies (MAbs)
- Recombinant Proteins
- Vaccines
- Antisense, RNAi, & Molecular Therapy
- Others
- Biosimilars
- Biologics
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Asia Pacific
- China
- India
- Latin America
- Brazil
- Middle East & Africa
- South Africa
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39095
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Biopharmaceutical CMO and CRO Market, By Source
7.1. Biopharmaceutical CMO and CRO Market, by Source, 2021-2030
7.1.1. Mammalian
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Non-mammalian
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Biopharmaceutical CMO and CRO Market, By Service Type
8.1. Biopharmaceutical CMO and CRO Market, by Service Type, 2021-2030
8.1.1. Contract Manufacturing
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Contract Research
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Biopharmaceutical CMO and CRO Market, By Product
9.1. Biopharmaceutical CMO and CRO Market, by Product, 2021-2030
9.1.1. Biologics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Biosimilars
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Biopharmaceutical CMO and CRO Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Source (2017-2030)
10.1.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.1.3. Market Revenue and Forecast, by Product (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Source (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.1.4.3. Market Revenue and Forecast, by Product (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Source (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.1.5.3. Market Revenue and Forecast, by Product (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Source (2017-2030)
10.2.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.3. Market Revenue and Forecast, by Product (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Source (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.4.3. Market Revenue and Forecast, by Product (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Source (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.5.3. Market Revenue and Forecast, by Product (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Source (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.6.3. Market Revenue and Forecast, by Product (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Source (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.7.3. Market Revenue and Forecast, by Product (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Source (2017-2030)
10.3.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.3. Market Revenue and Forecast, by Product (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Source (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.4.3. Market Revenue and Forecast, by Product (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Source (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.5.3. Market Revenue and Forecast, by Product (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Source (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.6.3. Market Revenue and Forecast, by Product (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Source (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.7.3. Market Revenue and Forecast, by Product (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Source (2017-2030)
10.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.3. Market Revenue and Forecast, by Product (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Source (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.4.3. Market Revenue and Forecast, by Product (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Source (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.5.3. Market Revenue and Forecast, by Product (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Source (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.6.3. Market Revenue and Forecast, by Product (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Source (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.7.3. Market Revenue and Forecast, by Product (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Source (2017-2030)
10.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.5.3. Market Revenue and Forecast, by Product (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Source (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.5.4.3. Market Revenue and Forecast, by Product (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Source (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
10.5.5.3. Market Revenue and Forecast, by Product (2017-2030)
Chapter 11. Company Profiles
11.1. Boehringer Ingelheim GmbH
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Lonza Group AG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Inno Biologics Sdn Bhd
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Rentschler Biopharma SE
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. JRS Pharma
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Biomeva GmbH
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. ProBioGen AG
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Toyobo Co., Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Samsung Biologics
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39095
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
